What are
artificial
exosomes?

Moving beyond natural limitations, our Artificial Exosomes (AEs) represent a new class of biopharmaceuticals. These engineered carriers offer a homogeneous, scalable, and customizable platform while inheriting the benefits of natural exosomes, setting the standard for reliable drug delivery systems.

Our AI platform accurately determines the most stable lipid composition ratios, engineering drug carriers that perform reliably from the lab to the clinic.

Moving beyond general delivery, our intelligent system accurately determines the compositional ratios that yield the best therapeutic cargo delivery customized for the specific biological demands of the target disease.